w26052104 mucosal immune activation in the female genital tract in hvtn702 and rv144 (rv306).
Published 3 years ago • 109 plays • Length 14:40Download video MP4
Download video MP3
Similar videos
-
16:35
w26052106 discovering correlates of risk in absence of overall protection to inform vaccine design
-
19:38
understanding the rectal mucosal immune environment and potential impacts on hiv transmission
-
2:41
scientists find new clues to how the hiv vaccine in rv144 may have worked
-
0:38
used syringe under the microscope is insane (real!)
-
47:43
hiv diagnostics update
-
16:41
mobs0102 - what drives persistent immune activation/inflammation in cart-treated hiv-1?
-
26:27
epithelial stem cell-based aids vaccine: mucosal immune responses and control of transmission
-
17:25
hbv prevention: new vaccines and the boundaries of hbv protection
-
3:21
iavi’s global call to access for monoclonal antibodies for covid-19 and other diseases
-
9:28
hepatitis b vaccination (1/2)
-
28:05
wepl0104 - toward an hiv vaccine
-
7:56
seph borrow: hiv immunology for vaccine design
-
15:03
update on hiv vaccine and monoclonal antibody | glenda e. gray, mbbch, fcpaeds (sa), dsc
-
16:36
updates to recommendation for vaccines in people with hiv
-
5:27
25 hiv multicultural hiv and hepatitis service mhahs
-
0:15
hiv treatments are now so good, they stop transmission of the virus. pass it on.
-
2:42
cytomegalovirus update: why isn’t there a vaccine? | idweek 2023